Income Statement SoftOx Solutions

Equities

SOFTX

NO0010811961

Biotechnology & Medical Research

Market Closed - Oslo Bors Other stock markets 15:45:00 05/06/2026 BST			5-day change	1st Jan Change
0.1248 ^NOK	+1.46%		+12.64%	+42.14%

06-05	SoftOx Solutions AS Enrolls First Participant In SIS-02 Phase 1 Clinical Study	CI
06-05	SoftOx Solutions Enrolls First Patient in Clinical Trial of Inhalation Therapy	MT

9b83630febccfa536bd211.9aVCWqPguRZszCd335if-9PnJwJ-V6aMm6VJflAFBNM.t8MVHMGB8lRcqEAgpdzltriPHmFPPZLh0fpwJiE9M5-_43MLlamUcTO8cg

Published financial data: SOFTOX SOLUTIONS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Other Revenues, Total	7.9M	7.11M	6.98M	7.91M	15.58M
Total Revenues	7.9M	7.11M	6.98M	7.91M	15.58M
Gross Profit	7.9M	7.11M	6.98M	7.91M	15.58M
Selling General & Admin Expenses, Total	21.11M	26.38M	7.79M	4.98M	6.09M
Depreciation & Amortization - (IS)	3.78M	3.9M	7.48M	5.37M	3.19M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	69.11M	67.89M	24.34M	30.02M	17.68M
Other Operating Expenses, Total	94M	98.17M	39.61M	40.38M	26.96M
Operating Income	-86.1M	-91.05M	-32.63M	-32.46M	-11.37M
Interest Expense, Total	-87.81K	-2.24M	-8.93M	-8.92M	-
Interest And Investment Income	32.9K	736K	59.41K	-	-
Net Interest Expenses	-54.9K	-1.5M	-8.87M	-8.92M	-
Other Non Operating Income (Expenses)	-134K	-1.14M	-574K	-9.08M	559K
EBT, Excl. Unusual Items	-86.29M	-93.7M	-42.08M	-50.46M	-10.81M
EBT, Incl. Unusual Items	-86.29M	-93.7M	-42.08M	-50.46M	-10.81M
Income Tax Expense	-20.89M	-22.56M	-2.63M	-7.51M	-
Earnings From Continuing Operations	-65.4M	-71.14M	-39.45M	-42.94M	-10.81M
Net Income to Company	-65.4M	-71.14M	-39.45M	-42.94M	-10.81M
Net Income - (IS)	-65.4M	-71.14M	-39.45M	-42.94M	-10.81M
Net Income to Common Incl Extra Items	-65.4M	-71.14M	-39.45M	-42.94M	-10.81M
Net Income to Common Excl. Extra Items	-65.4M	-71.14M	-39.45M	-42.94M	-10.81M
Per Share Items
Net EPS - Basic	-6.32	-6.88	-3.68	-0.02	-0
Basic EPS - Continuing Operations	-6.32	-6.88	-3.68	-0.02	-0
Basic Weighted Average Shares Outstanding	10.34M	10.34M	10.73M	1.95B	2.39B
Net EPS - Diluted	-6.32	-6.88	-3.68	-0.02	-0
Diluted EPS - Continuing Operations	-6.32	-6.88	-3.68	-0.02	-0
Diluted Weighted Average Shares Outstanding	10.34M	10.34M	10.73M	1.95B	2.39B
Normalized Basic EPS	-5.21	-5.66	-2.45	-0.02	-0
Normalized Diluted EPS	-5.21	-5.66	-2.45	-0.02	-0
Supplemental Items
EBITDA	-82.32M	-87.15M	-25.16M	-27.09M	-8.18M
EBITA	-82.72M	-87.74M	-28.38M	-21.18M	-8.18M
EBIT	-86.1M	-91.05M	-32.63M	-32.46M	-11.37M
Total Revenues (As Reported)	7.9M	7.11M	6.98M	7.91M	15.58M
Effective Tax Rate - (Ratio)	24.21	24.08	6.26	14.89	-
Total Deferred Taxes	-20.89M	-22.56M	-2.63M	-7.51M	-
Normalized Net Income	-53.93M	-58.56M	-26.3M	-31.54M	-6.76M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	44.3M	43.8M	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	56.98M	6.91M	7.65M	10.51M	19.79M
Total Cash And Short Term Investments	56.98M	6.91M	7.65M	10.51M	19.79M
Other Receivables	8.67M	7.79M	949K	12.94K	-
Total Receivables	8.67M	7.79M	949K	12.94K	-
Inventory	196K	-	-	-	-
Other Current Assets, Total	-	-	-	-1	-
Total Current Assets	65.85M	14.7M	8.6M	10.53M	19.79M
Gross Property Plant And Equipment	5.31M	-	6.44M	6.44M	-
Accumulated Depreciation	-1.81M	-	-5.79M	-6.44M	-
Net Property Plant And Equipment	3.49M	3.89M	647K	0	-
Goodwill	-	-	-	-	-
Other Intangibles, Total	7.37M	7.93M	11.3M	26.41M	14.14M
Deferred Tax Assets Long-Term	51.35M	74.05M	76.69M	84.2M	-
Other Long-Term Assets, Total	2	2	-1	-	-
Total Assets	128M	101M	97.24M	121M	33.93M
Liabilities
Accounts Payable, Total	6.03M	11.32M	20.94M	6.38M	997K
Accrued Expenses, Total	37.99K	619K	-69.58K	-569K	-243K
Other Current Liabilities	11.91M	8.83M	28.41M	20.14M	10.22M
Total Current Liabilities	17.98M	20.76M	49.28M	25.96M	10.98M
Other Non Current Liabilities	350K	41.06M	45.59M	-	-
Total Liabilities	18.33M	61.83M	94.87M	25.96M	10.98M
Common Stock, Total	207K	207K	215K	39.03M	47.81M
Additional Paid In Capital	110M	38.53M	2.15M	56.16M	-
Retained Earnings	-	-	-	-	-
Comprehensive Income and Other	-	-	1	-	-24.85M
Total Common Equity	110M	38.74M	2.37M	95.18M	22.95M
Total Equity	110M	38.74M	2.37M	95.18M	22.95M
Total Liabilities And Equity	128M	101M	97.24M	121M	33.93M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10.34M	10.34M	10.73M	1.95B	2.39B
ECS Total Common Shares Outstanding	10.34M	10.34M	10.73M	1.95B	2.39B
Book Value / Share	10.61	3.75	0.22	0.05	0.01
Tangible Book Value	102M	30.81M	-8.93M	68.77M	8.82M
Tangible Book Value Per Share	9.9	2.98	-0.83	0.04	0
Total Debt	0	0	0	0	0
Net Debt	-56.98M	-6.91M	-7.65M	-10.51M	-19.79M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	196K	-	-	-	-
Machinery, Total	5.31M	-	6.44M	6.44M	-
Full Time Employees	20	24	7	2	2
Part Time Employees	1	1	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-65.4M	-71.14M	-39.45M	-42.94M	-10.81M
Depreciation & Amortization - CF	401K	580K	3.23M	-5.91M	-
Amortization of Goodwill and Intangible Assets - (CF)	3.38M	3.32M	4.25M	11.29M	3.19M
Depreciation & Amortization, Total	3.78M	3.9M	7.48M	5.37M	3.19M
Other Operating Activities, Total	-20.89M	-22.56M	-2.63M	92.52M	3.72M
Change In Accounts Receivable	286K	885K	6.84M	936K	13K
Change In Inventories	2.77M	196K	-	-	-
Change in Other Net Operating Assets	6.89M	2.78M	28.52M	-23.33M	-14.98M
Cash from Operations	-72.56M	-85.94M	757K	32.56M	-18.87M
Capital Expenditure	-4.6M	-4.85M	-7.61M	-19.83M	-
Sale of Property, Plant, and Equipment	-	-	-	-	9.08M
Cash from Investing	-4.6M	-4.85M	-7.61M	-19.83M	9.08M
Issuance of Common Stock	89.02M	-	3.08M	35.74M	19.09M
Other Financing Activities, Total	10.32M	40.71M	4.52M	-45.61M	-23K
Cash from Financing	99.34M	40.71M	7.6M	-9.86M	19.07M
Miscellaneous Cash Flow Adjustments	-	-	-1.86K	-1.86K	-2K
Net Change in Cash	22.18M	-50.08M	746K	2.86M	9.28M
Supplemental Items
Levered Free Cash Flow	-44.73M	-55.4M	9.25M	-62.72M	-18.88M
Unlevered Free Cash Flow	-44.68M	-54M	14.83M	-57.14M	-18.88M
Change In Net Working Capital	-9.95M	-3.87M	-35.36M	22.39M	14.97M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-49.97	-49.78	-20.62	-18.58	-9.17
Return on Total Capital	-57.88	-76.66	-99.24	-41.6	-12.03
Return On Equity %	-70.34	-95.83	-191.93	-88.05	-18.31
Return on Common Equity	-70.34	-95.83	-191.93	-88.05	-18.31
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	267.21	370.87	111.67	62.99	39.06
EBITDA Margin %	-1.04K	-1.23K	-360.4	-342.32	-52.49
EBITA Margin %	-1.05K	-1.23K	-406.65	-267.58	-52.49
EBIT Margin %	-1.09K	-1.28K	-467.55	-410.2	-72.97
Income From Continuing Operations Margin %	-827.74	-1K	-565.17	-542.64	-69.39
Net Income Margin %	-827.74	-1K	-565.17	-542.64	-69.39
Net Avail. For Common Margin %	-827.74	-1K	-565.17	-542.64	-69.39
Normalized Net Income Margin	-682.56	-823.25	-376.82	-398.5	-43.37
Levered Free Cash Flow Margin	-566.16	-778.75	132.53	-792.46	-121.16
Unlevered Free Cash Flow Margin	-565.46	-759.09	212.52	-722.05	-121.16
Asset Turnover
Asset Turnover	0.07	0.06	0.07	0.07	0.2
Fixed Assets Turnover	2.13	1.93	3.08	24.45	-
Short Term Liquidity
Current Ratio	3.66	0.71	0.17	0.41	1.8
Quick Ratio	3.65	0.71	0.17	0.41	1.8
Operating Cash Flow to Current Liabilities	-4.04	-4.14	0.02	1.25	-1.72
Long Term Solvency
Total Liabilities / Total Assets	14.31	61.48	97.57	21.43	32.35
EBIT / Interest Expense	-980.59	-40.69	-3.65	-3.64	-
EBITDA / Interest Expense	-937.5	-38.95	-2.82	-3.04	-
(EBITDA - Capex) / Interest Expense	-989.84	-41.12	-3.67	-5.26	-
Net Debt / EBITDA	0.69	0.08	0.3	0.39	2.42
Net Debt / (EBITDA - Capex)	0.66	0.08	0.23	0.22	2.42
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-19.69	-9.97	-1.88	13.38	96.92
Gross Profit, 1 Yr. Growth %	-19.69	-9.97	-1.88	13.38	96.92
EBITDA, 1 Yr. Growth %	69.17	6.07	-71.14	7.69	-69.81
EBITA, 1 Yr. Growth %	69.04	6.06	-67.65	-25.39	-61.37
EBIT, 1 Yr. Growth %	67.63	5.75	-64.16	-0.53	-64.97
Earnings From Cont. Operations, 1 Yr. Growth %	74.85	8.77	-44.55	8.86	-74.82
Net Income, 1 Yr. Growth %	74.85	8.77	-44.55	8.86	-74.82
Normalized Net Income, 1 Yr. Growth %	73.58	8.59	-55.09	19.9	-78.57
Diluted EPS Before Extra, 1 Yr. Growth %	40.8	8.77	-46.54	-99.4	-79.45
Inventory, 1 Yr. Growth %	-93.41	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-10.62	11.36	-83.36	-100	-
Total Assets, 1 Yr. Growth %	46.68	-21.47	-3.31	24.58	-71.99
Tangible Book Value, 1 Yr. Growth %	46.08	-69.9	-129	-869.71	-87.18
Common Equity, 1 Yr. Growth %	43.98	-64.7	-93.89	3.92K	-75.88
Cash From Operations, 1 Yr. Growth %	20.16	18.43	-100.88	4.2K	-157.94
Capital Expenditures, 1 Yr. Growth %	-40.07	5.63	56.75	160.67	-
Levered Free Cash Flow, 1 Yr. Growth %	-11.63	24.25	-116.7	-777.96	-69.89
Unlevered Free Cash Flow, 1 Yr. Growth %	-11.74	21.26	-127.47	-485.21	-66.96
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	38.84	-14.97	-6.01	5.48	49.42
Gross Profit, 2 Yr. CAGR %	38.84	-14.97	-6.01	5.48	49.42
EBITDA, 2 Yr. CAGR %	102.03	33.83	-44.67	-44.25	-42.98
EBITA, 2 Yr. CAGR %	102.12	33.9	-41.42	-50.87	-46.32
EBIT, 2 Yr. CAGR %	98.42	33.14	-38.44	-40.29	-40.97
Earnings From Cont. Operations, 2 Yr. CAGR %	100.09	37.91	-22.34	-22.3	-47.65
Net Income, 2 Yr. CAGR %	100.09	37.91	-22.34	-22.3	-47.65
Normalized Net Income, 2 Yr. CAGR %	97.25	37.29	-30.17	-26.62	-49.31
Diluted EPS Before Extra, 2 Yr. CAGR %	73.21	23.76	-23.74	-94.34	-96.49
Net Property, Plant and Equip., 2 Yr. CAGR %	280.17	-0.23	-56.95	-	-
Total Assets, 2 Yr. CAGR %	10.46	7.32	-12.86	9.75	-40.93
Tangible Book Value, 2 Yr. CAGR %	12.04	-33.69	-70.46	49.39	-0.66
Common Equity, 2 Yr. CAGR %	12.65	-28.71	-85.32	56.75	211.45
Cash From Operations, 2 Yr. CAGR %	162.11	19.29	-89.79	-38.45	399.33
Capital Expenditures, 2 Yr. CAGR %	19.82	-20.44	28.67	102.14	-
Levered Free Cash Flow, 2 Yr. CAGR %	189.3	4.61	-54.45	6.4	42.87
Unlevered Free Cash Flow, 2 Yr. CAGR %	191.63	3.28	-42.28	2.87	12.82
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.26	20.17	-10.81	0.05	29.88
Gross Profit, 3 Yr. CAGR %	22.26	20.17	-10.81	0.05	29.88
EBITDA, 3 Yr. CAGR %	72.02	62.88	-19.74	-30.92	-54.56
EBITA, 3 Yr. CAGR %	71.83	63.03	-16.6	-36.5	-54.66
EBIT, 3 Yr. CAGR %	70.78	60.87	-14.03	-27.76	-50.01
Earnings From Cont. Operations, 3 Yr. CAGR %	71.66	63.3	1.79	-13.08	-46.63
Net Income, 3 Yr. CAGR %	71.66	63.3	1.79	-13.08	-46.63
Normalized Net Income, 3 Yr. CAGR %	70.33	61.66	-5.4	-16.38	-51.31
Diluted EPS Before Extra, 3 Yr. CAGR %	22.72	48.33	-6.45	-84.85	-91.31
Net Property, Plant and Equip., 3 Yr. CAGR %	120.32	152.48	-45.08	-	-
Total Assets, 3 Yr. CAGR %	76.24	-1.42	3.65	-1.84	-30.38
Tangible Book Value, 3 Yr. CAGR %	109.92	-27.7	-49.67	-12.42	-34.1
Common Equity, 3 Yr. CAGR %	96.75	-23.48	-68.57	-4.63	-16.01
Cash From Operations, 3 Yr. CAGR %	69.35	101.13	-76.77	-23.44	-39.67
Capital Expenditures, 3 Yr. CAGR %	47.1	14.89	-0.26	62.81	-
Levered Free Cash Flow, 3 Yr. CAGR %	66.31	118.03	-43.25	12.05	-30.15
Unlevered Free Cash Flow, 3 Yr. CAGR %	66.24	117.42	-33.58	8.67	-29.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	139.15	489.41	10.06	14.06	9.63
Gross Profit, 5 Yr. CAGR %	139.15	489.41	10.06	14.06	9.63
EBITDA, 5 Yr. CAGR %	57.21	48.18	9.24	6.08	-30
EBITA, 5 Yr. CAGR %	55.81	48.04	11.73	0.9	-30.08
EBIT, 5 Yr. CAGR %	57.06	47.22	13.55	8.22	-26.03
Earnings From Cont. Operations, 5 Yr. CAGR %	60.11	49.87	25	21.33	-21.98
Net Income, 5 Yr. CAGR %	60.11	49.87	25	21.33	-21.98
Normalized Net Income, 5 Yr. CAGR %	57.49	48.05	19.23	17.87	-26.3
Diluted EPS Before Extra, 5 Yr. CAGR %	17.3	12.72	1.45	-59.84	-74.85
Net Property, Plant and Equip., 5 Yr. CAGR %	42.94	52.5	14.66	-	-
Total Assets, 5 Yr. CAGR %	70.61	26.51	32.97	2.91	-17.22
Tangible Book Value, 5 Yr. CAGR %	204.28	5.14	-4.19	-3.35	-33.94
Common Equity, 5 Yr. CAGR %	113.37	7.61	-30.32	1.94	-21.34
Cash From Operations, 5 Yr. CAGR %	-	41.14	-44.93	25.25	-20.76
Capital Expenditures, 5 Yr. CAGR %	-	26.72	39.43	44.02	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	36.01	-1	63.64	-17.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	35.35	8.81	61.18	-17.9